Case Report
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 21, 2016; 22(43): 9654-9660
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9654
Synchronous occurrence of a hepatic myelolipoma and two hepatocellular carcinomas
Shao-Yan Xu, Hai-Yang Xie, Lin Zhou, Shu-Sen Zheng, Wei-Lin Wang
Shao-Yan Xu, Hai-Yang Xie, Lin Zhou, Shu-Sen Zheng, Wei-Lin Wang, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, China
Shao-Yan Xu, Hai-Yang Xie, Lin Zhou, Shu-Sen Zheng, Wei-Lin Wang, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, China
Shao-Yan Xu, Hai-Yang Xie, Lin Zhou, Shu-Sen Zheng, Wei-Lin Wang, Key Laboratory of Organ Transplantation, Hangzhou 310003, Zhejiang Province, China
Shao-Yan Xu, Hai-Yang Xie, Lin Zhou, Shu-Sen Zheng, Wei-Lin Wang, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou 310003, Zhejiang Province, China
Author contributions: Xu SY collected case data, prepared the photos and wrote the manuscript; Xie HY, Zhou L, Zheng SS and Wang WL proofread and revised the manuscript; all authors approved the final version to be published.
Supported by the National Basic Research Program (973 Program) in China, No. 2013CB531403; and the National Natural Science Foundation of China, No. 81572307.
Institutional review board statement: The study was reviewed and approved by the Institutional Review Board of the First Affiliated Hospital, School of Medicine, Zhejiang University.
Informed consent statement: Informed consent was obtained from the patient.
Conflict-of-interest statement: No commercial or associative interest in any form has been received or will be received from a commercial party related directly or indirectly to the subject of this paper.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Wei-Lin Wang, PhD, MD, Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, No. 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China. wam@zju.edu.cn
Telephone: +86-571-87236466 Fax: +86-571-87236466
Received: September 7, 2016
Peer-review started: September 8, 2016
First decision: September 28, 2016
Revised: October 10, 2016
Accepted: October 19, 2016
Article in press: October 19, 2016
Published online: November 21, 2016
Core Tip

Core tip: Hepatic myelolipoma is extremely rare. To date, only 10 cases have been reported in the English-language medical literature. In the present study, we report the first case of the synchronous occurrence of a hepatic myelolipoma and two hepatocellular carcinomas in different liver sections of one patient, who received a right hepatectomy, a left hepatic lobectomy, and a cholecystectomy. We also highlight the diagnosis and treatment of a hepatic myelolipoma and conduct a literature review to deepen the understanding of the subject.